User:Mr. Ibrahem/Dolutegravir/lamivudine

Dolutegravir/lamivudine, sold under the brand name Dovato, is a combination medication used to treat HIV/AIDS. It may be a first line treatment option. It may, also be the only medication a person requires. It is taken by mouth.

Common side effects are headache, diarrhea, nausea, and difficulty sleeping. Other side effects may include allergic reactions, rash, and liver problems. While there is no evidence of harm in pregnancy, such use has not been well studied. It contains dolutegravir, an integrase inhibitor, and lamivudine, a reverse-transcriptase inhibitor. Dolutegravir stops the activity of integrase, while lamivudine stops the activity of nucleoside reverse transcriptase.

The combination was approved for medical use in the United States and Europe in 2019. It is a generic medication. In the United Kingdom a month of treatment costs the NHS about £660 as of 2021. In the United States this amount costs about 2,500 USD.